Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

1

Funds

1

About Jinyuan Kuntong

Jinyuan Kuntong is a private equity firm based out of Guangzhou, China.

Jinyuan Kuntong Headquarter Location

No. 3, 4th Luoxuan Road Block 2, Floor 2 Suite 201

Guangzhou, Guangdong, 510005,

China

86 20 22283222

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Jinyuan Kuntong Investments

1 Investments

Jinyuan Kuntong has made 1 investments. Their latest investment was in Dimai Biotech as part of their Series A on April 4, 2018.

CBI Logo

Jinyuan Kuntong Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/15/2018

Series A

Dimai Biotech

Yes

1

Date

4/15/2018

Round

Series A

Company

Dimai Biotech

Amount

New?

Yes

Co-Investors

Sources

1

Jinyuan Kuntong Fund History

1 Fund History

Jinyuan Kuntong has 1 fund, including Guangzhou Jinhe Equity Investment Management LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Guangzhou Jinhe Equity Investment Management LP

Diversified Private Equity

1

Closing Date

Fund

Guangzhou Jinhe Equity Investment Management LP

Fund Type

Diversified Private Equity

Status

Amount

Sources

1

Jinyuan Kuntong Team

1 Team Member

Jinyuan Kuntong has 1 team member, including current Managing Director, Zhifei Wang.

Name

Work History

Title

Status

Zhifei Wang

Managing Director

Current

Name

Zhifei Wang

Work History

Title

Managing Director

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.